Onward Medical N.V.
EBR:ONWD.BR
6.04 (EUR) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 0.532 | 2.148 | 1.399 | 0.8 | 0.554 | 0.474 |
| Cost of Revenue
| 15.35 | 14.687 | 4.047 | 2.309 | 0.838 | 1.041 |
| Gross Profit
| -14.818 | -12.539 | -2.648 | -1.509 | -0.284 | -0.567 |
| Gross Profit Ratio
| -27.853 | -5.838 | -1.893 | -1.886 | -0.513 | -1.196 |
| Reseach & Development Expenses
| 13.841 | 13.138 | 7.932 | 5.823 | 5.356 | 4.722 |
| General & Administrative Expenses
| 11.327 | 8.072 | 6.241 | 2.671 | 2.247 | 1.246 |
| Selling & Marketing Expenses
| 2.943 | 1.951 | 1.516 | 0.394 | 0.261 | 0.098 |
| SG&A
| 15.734 | 10.023 | 7.757 | 3.065 | 2.508 | 1.344 |
| Other Expenses
| -8.93 | 7.318 | 8.796 | 4.316 | 2.07 | 1.298 |
| Operating Expenses
| 20.645 | 17.341 | 24.485 | 13.204 | 9.934 | 7.364 |
| Operating Income
| -35.463 | -32.028 | -28.532 | -15.512 | -10.772 | -8.405 |
| Operating Income Ratio
| -66.66 | -14.911 | -20.395 | -19.39 | -19.444 | -17.732 |
| Total Other Income Expenses Net
| -0.611 | -1.51 | -5.713 | -4.482 | -2.672 | -1.489 |
| Income Before Tax
| -36.074 | -33.538 | -34.245 | -19.994 | -13.444 | -9.894 |
| Income Before Tax Ratio
| -67.808 | -15.614 | -24.478 | -24.993 | -24.267 | -20.873 |
| Income Tax Expense
| 0.107 | -0.766 | 0.069 | 0.02 | 0.039 | 0.018 |
| Net Income
| -36.181 | -32.772 | -34.314 | -20.014 | -13.483 | -9.912 |
| Net Income Ratio
| -68.009 | -15.257 | -24.528 | -25.018 | -24.338 | -20.911 |
| EPS
| -1.2 | -1.09 | -1.14 | -0.96 | -0.65 | -0.48 |
| EPS Diluted
| -1.2 | -1.09 | -1.14 | -0.96 | -0.65 | -0.48 |
| EBITDA
| -35.234 | -31.288 | -28.319 | -15.293 | -10.544 | -8.173 |
| EBITDA Ratio
| -66.229 | -14.566 | -20.242 | -19.116 | -19.032 | -17.243 |